SCHEMBL6765024

SCHEMBL6765024

NC(O)c1ccccc1C(N)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
HIF1A Q16665 2/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2C P18825 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.39
DPP4 P27487 2/20 0.38
F2 P00734 1/20 0.38
GABRA1 P14867 2/20 0.38
GABRB2 P47870 2/20 0.38
PTGS1 P23219 2/20 0.37
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37
XIAP P98170 1/20 0.37
SLC7A5 Q01650 1/20 0.37
AOC3 Q16853 1/20 0.34
TSHR P16473 2/20 0.33
FAAH O00519 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23073315 0.83 CYP3A4 (0.45) LMNAHIF1AADRA2AADRA2CKDM4E
SCHEMBL640127 0.83 GABRA1 (0.54) LMNAHIF1AKDM4EALDH1A1GABRA1
SCHEMBL20256365 0.81 CES2 (0.48) ALDH1A1CYP3A4SLC6A2
SCHEMBL1669099 0.81 ESR1 (0.50) LMNAHIF1AADRA2AADRA2CKDM4E
Bromide SCHEMBL209321 0.81 GABRA1 (0.52) LMNAHIF1AADRA2AADRA2CKDM4E
SCHEMBL12232405 0.77 NOS3 (0.36) LMNAHIF1AADRA2AADRA2CKDM4E
SCHEMBL14349091 0.77 NOS3 (0.36) LMNAHIF1AADRA2AADRA2CKDM4E
SCHEMBL5141202 0.77 ALDH1A1 (0.56) ADRA2AADRA2CALDH1A1AOC3TSHR
SCHEMBL3131040 0.75 TSHR (0.41) ADRA2AKDM4EALDH1A1TSHRCA1
SCHEMBL18929401 0.75 ALDH1A1 (0.46) LMNAHIF1AADRA2AADRA2CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3173408-A1 PHENYL TETRAHYDROISOQUINOLINE COMPOUND SUBSTITUTED WITH HETEROARYL Taisho Pharmaceutical Co., Ltd. (JP) 2017-05-31 EP disclosed
US-6750343-B2 REACTING A 5- AND 6- HALOMETHYL QUINOXALINE WITH A WATER-SOLUBLE NUCLEOPHILE, DEHALOGENATION, DECHLORINATION, DEBROMINATION, HYDROXYLATION; CHEMICAL INTERMEDIATES FOR PHARMACEUTICAL COMPOUNDS AIR PRODUCTS AND CHEMICALS, INC. 2004-06-15 US disclosed
US-20030166934-A1 Methods for preparing 5- and 6-benzyl-functionalized quinoxalines BURDENIUC JUAN JESUS (US) 2003-09-04 US disclosed
US-20030158411-A1 Methods for preparing 5- and 6-benzyl-functionalized quinoxalines BURDENIUC JUAN JESUS (US) 2003-08-21 US disclosed
US-6548670-B1 Reacting chloro(or bromo)alkylquinoxaline with nucleophilic compound in presence of phase transfer catalyst to make hydroxyalkylquinoxaline; debromination, dechlorination, hydroxylation AIR PRODUCTS AND CHEMICALS, INC. 2003-04-15 US disclosed
EP-1279668-A1 Methods for preparing 5- and 6-benzyl functionalized quinoxalines AIR PRODUCTS AND CHEMICALS, INC. (US) 2003-01-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166934-A1 Methods for preparing 5- and 6-benzyl-functionalized quinoxalines NUDT1, ALKBH5, INMT LMNA 1762/4885HIF1A 3987/4885ADRA2A 2156/4885
US-20030158411-A1 Methods for preparing 5- and 6-benzyl-functionalized quinoxalines NUDT1, ALKBH5, INMT LMNA 1762/4885HIF1A 3987/4885ADRA2A 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.